AGGF1P7

Across TCGA pan-cancer cohorts, AGGF1P7 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated AGGF1P7 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher AGGF1P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGGF1P7 expression acts as an unfavorable survival marker.

ESCA and LUSC are the cancer types where AGGF1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	II,III,IV	0.125	0.838	.006	36	view →
LUSC	OS	Tertile	II,III,IV	0.200	0.631	.018	27	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

AGGF1P7–ESCA (DFS)

Open the ESCA breakdown →